Medtronic Agrees to Divest Avecor's Assets to Settle FTC Charges
Date
Medtronic, Inc. will divest Avecor's non-occlusive arterial pump assets to settle Federal Trade Commission charges that Medtronic's $106 million acquisition of its competitor would lessen competition...